Physician

Adam Arebi Garsa, M.D.

According to 2025 Medicare claims, Adam Garsa, M.D. (NPI: 1306008768) practices radiation oncology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is USC CARE MEDICAL GROUP, INC (NPI: 1902846306; TIN: 954540991) and primary practice location at 90089-0112. Garsa is affiliated with the Lore Health ACO (ACO ID: A5192), participating under the MSSP model.

Garsa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 188 traditional Medicare patients, billed 1,818 HCPCS/CPT codes, and received $138,308 in Medicare payments. The top billing code was 77338 (Design and construction of radiation treatment device for high precision radiation therapy). Part D data shows 102 prescription claims across 38 beneficiaries totaling $2,800 in drug costs, led by Lidocaine Hcl Viscous (Lidocaine Hcl). Open Payments data shows 2 records totaling $51. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $102,331 and ending at $138,308. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,906 and ending at $2,800. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.